by Matthias Burel | Nov 8, 2023 | Clinical Trials
TitleAtrial Fibrillation detection in OBESity using Ehealth TopicObesity is a global epidemic. Obesity is associated with an increased risk of atrial fibrillation (AF). AF is the most common sustained cardiac rhythm disorder in humans with potentially life threatening...
by Matthias Burel | Nov 8, 2023 | Clinical Trials
TitleCase-finding Study to Detect and Quantify Episodes of Absolute Arrhythmia Using an Automated, Wearable Monitoring System (Smart in OAC) TopicTo demonstrate that patients with previously unknown atrial arrhythmias can be detected by a wearable in combination with...
by Matthias Burel | Nov 8, 2023 | Clinical Trials
TitleDetermine AF Burden with PPG Trial – Detection and Quantification of Episodes of Atrial Fibrillation Using a Wearable with Photoplethysmographic (PPG) Sensor TopicEvaluation of the performance of the Corsano Cardiowatch 287 Bracelet in identifying AF episodes and...
by Matthias Burel | Nov 8, 2023 | Clinical Trials
TitleRECAMO: REmote CArdiac MOnitoring by the Corsano Cardiowatch 287-2 of BP and AF RationaleWearables have the potential to monitor patients remotely. The Corsano CardioWatch 287-2 is such a medical device that can monitor atrial fibrillation and long-term blood...
by Matthias Burel | Oct 8, 2023 | Publications
AF detection using Smartphone Apps 70 patients in an AF rhythm and 70 patients in sinus rhythm were recruited. Mean age was 73±12 (60% male) in the AF group, 59±20 in the sinus rhythm group (66% male). The BeatScanner app had a sensitivity of 89% (95% CI: 79-95%) and...
